AcelRx Pharmaceuticals, Inc.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for th…
Drug Manufacturers - Specialty & Generic
US, Hayward [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about AcelRx Pharmaceuticals, Inc.'s gradings, price targets and earnings estimates. None
Reported
Past Estimate Consensus
Future Estimate Consensus
AcelRx Pharmaceuticals, Inc. can't present any analysts estimates at the moment detail analysis.